The US FDA has accepted Airway Therapeutics' Investigational New Drug (IND) application to develop AT-100 (rhSP-D) as a treatment for COVID-19. Cincinnati biopharmaceutical company, Airway Therapeutics is leveraging the FDA’s...

View the Online Magazine

- Advertisement -

Launches

Newly launched British biotech pioneers ground-breaking potential treatments for COVID-19

A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and...

ACG launches ACGcaps™ NTone and ACGcaps™ TSafe Capsules

ACGcaps™ NTone is a portfolio of naturally coloured capsules and with no e-number. The aesthetically appealing colour solutions include Ocean Blue, Sunny Yellow, Desert...

CEPI launches $3.5bn plan to tackle risk of future pandemics and epidemics

CEPI, the Coalition for Epidemic Preparedness Innovations, has launched a US$3.5 billion plan to dramatically reduce or even eliminate the future risk of pandemics...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is ‘safe and effective’

The Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) reaffirmed the  benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh...

Clinigen signs Africa and Asia distribution agreement with Amgen

Clinigen Group, the global pharmaceutical Products and Services company, has signed a distribution agreement with Amgen to supply part of its product portfolio to...

New full-service packing design agency launched from state-of-the-art R&D facility in East Yorkshire

A new full-service packaging design, innovation and development agency, Design Innovation Development (DiD), has been launched for pharmaceutical and healthcare businesses, building on nearly...

Sealed Air continues to play critical role in packaging solutions to support COVID-19 needs

As an industry leader in sustainable packaging solutions and systems, Sealed Air Corporation is proud to play a role in providing the essential packaging...

Approvals

FDA accepts Airway’s IND to develop novel recombinant protein for COVID-19

The US FDA has accepted Airway Therapeutics' Investigational New Drug (IND) application to develop AT-100 (rhSP-D) as a treatment for COVID-19. Cincinnati biopharmaceutical company, Airway...

FDA allows SPI to test ebselen as novel COVID-19 treatment

The FDA has allowed two Phase 2 studies to begin testing ebselen (SPI-1005) in COVID-19 patients, Sound Pharmaceuticals, Inc. (SPI) has announced. SPI is developing...

Manufacturiung

Finance

Research & Development
Latest

Biogen and Bio-Thera Solutions to develop Actemra biosimilar

Biogen and Bio-Thera Solutions have entered into a commercialisation and license agreement to develop, manufacture and commercialise BAT1806, a Phase 3 clinical stage anti-interleukin-6...

Trial shows leishmaniasis vaccine safe and induces immune responses in patients

The results of the first clinical trial of a new vaccine for a neglected tropical disease have demonstrated that it is safe and induces...

Claritas to expand R-107 program to include treatment of sepsis

Californian biotech, Claritas Pharmaceuticals, is expanding its R-107 development program to include the treatment of COVID-19 related sepsis (the leading cause of death in...

Moderna & Catalent expand collaboration

Moderna and Catalent have expanded their strategic collaboration to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine...

Pfizer-BioNTech COVID-19 vaccine maintains efficiency in latest results

Pfizer and BioNTech have reported updated topline results showing the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, was 91.3% effective against COVID-19, measured seven days through up...

Appointments

- Advertisement -